XBIT
XBiotech Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.95
−2.01%Oct 23, 2026, 13:17 UTC
XBiotech Inc. announced that its board elected Jan-Paul Simard and Sushma Shivaswamy to serve as co-chief executive officers, effective October 23, 2026.
Source:Oct 19, 2026, 13:00 UTC
XBiotech Inc. announced final Phase II TASKIN trial results showing 61.3% 12-month overall survival and meeting the prespecified primary efficacy success criterion.
Source: